This inventor holds 25 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Transdermal Drug Delivery. Top assignees: Alza Corporation, Powderject Research Limited, Adamas Pharmaceuticals, Inc.. Active years: 1976-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxford, GB (1998)
- Fremont, CA (US) (2007)
- Palo Alto, CA (US) (1976 - 2011)
Company Filing History:
16 out of 1,062 
4 out of 35 
2 out of 29 
Years Active: 1976-2011
Areas of Expertise:
Title: Innovations and Contributions of Terry L. Burkoth in Influenza Treatment
Introduction
Terry L. Burkoth is a notable inventor based in Palo Alto, California, known for his significant contributions to the field of antiviral treatments, particularly in the fight against influenza. With an impressive portfolio of 25 patents, Burkoth has dedicated his career to advancing medical science through innovative solutions.
Latest Patents
Among Terry L. Burkoth's latest patents are compositions and kits specifically designed for treating influenza. These include novel combinations of M2 inhibitors, such as amantadine and rimantadine, and ribavirin, alongside neuraminidase inhibitors. His work details oral dosage forms that provide effective antiviral combinations, with specific amounts ranging from 75-250 mg of the M2 inhibitor and 100-400 mg of ribavirin. The formulations not only focus on treatment but also explore methods for prophylaxis against influenza, showcasing Burkoth's commitment to developing comprehensive solutions.
Career Highlights
Throughout his career, Burkoth has worked with prominent organizations, notably Alza Corporation and Powderject Research Limited. His experiences at these companies have allowed him to refine his expertise and contribute substantially to research initiatives that have practical implications in public health.
Collaborations
Collaboration has played a vital role in Burkoth's career. He has had the opportunity to work alongside several esteemed colleagues, including Liang C. Dong and Michael H. Dealey. These partnerships within the industry have not only enhanced Burkoth's work but have also fostered a collaborative environment conducive to innovation.
Conclusion
Terry L. Burkoth exemplifies the spirit of innovation within the medical field through his patent portfolio and collaborative efforts. His latest contributions to influenza treatment reflect a commitment to improving healthcare outcomes. With ongoing advancements and innovations, Burkoth continues to play a crucial role in the development of antiviral therapies, impacting lives on a global scale.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile